Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Revenue

Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at IDEXX Laboratories IDXX is $1.29 billion. IDEXX had $223.99 million in total cash for the latest quarter. The trailing-twelve-month revenue at Meridian Bioscience VIVO is $178.82 million. Meridian Bioscience's operating margin for the same period is 29.72%. The trailing-twelve-month revenue at Abaxis ABAX is $178.79 million. Abaxis' PEG ratio is 3.61. The trailing-twelve-month revenue at Quidel QDEL is $155.74 million. Quidel's ROE for the same period is 2.59%.